A useful study brief does not try to replace scientific judgement. It makes the decision, identities, design, measurements, evidence requirements, deviations and accountable approvals explicit before execution.
Identify the material and biological system precisely
Names that are convenient inside one team can become ambiguous at an organisational boundary. Assign the test material a unique identifier and version. Record the declared construct or composition, provenance, relevant handling constraints and a non-secret verification reference where appropriate. Proprietary sequences do not need to enter a public system for the handoff to preserve an agreed identifier or supplied hash.
The cell context needs the same discipline. Record the exact cell line or model, source, authentication evidence and date, relevant passage or state information, contamination status and biological variables that may affect interpretation. NIH and NIST both treat resource identity and authentication as part of research confidence, while also making clear that the suitable method depends on the biological resource.
- Unique material ID and version
- Declared material provenance and handling boundary
- Exact cell line or model rather than a family label
- Source and authentication evidence
- Relevant state, passage and contamination information
- Owner for resolving identity conflicts
Make the study design inspectable
A Study Contract should record the design values supplied or approved by the project scientist: conditions, controls, timepoints, experimental units, biological and technical replication, planned exclusions and any randomisation or blinding that matters to the context. SingularCell can require these fields and flag contradictions. It must not invent the correct control set or replicate count.
Distinguish a missing value from a deliberate decision. “Not provided,” “not applicable” and “scientist approved” are different states. Making that difference visible prevents a blank field from silently becoming an assumption at the receiving laboratory.
- Scientist-defined conditions and controls
- Timepoints and experimental units
- Biological versus technical replicate identity
- Randomisation, blinding and planned exclusions where relevant
- Supplied criteria with source and approval state
- Unresolved items that block the handoff
Describe the measurement in its real context
A result label is not a measurement definition. Record the intended measurand or readout, assay context, instrument and software versions, calibration or control evidence, raw and processed data formats and known limits or sources of interference. NIST's cell-characterisation and measurement-assurance work emphasises that confidence depends on intended use, method context and sources of variability.
This context is especially important when a sponsor and laboratory use similar terminology for methods that are not demonstrably equivalent. Mapping terms into the same schema helps people compare declarations; it does not prove that the methods or laboratories produce interchangeable results.
- Intended measurand or readout
- Assay and measurement context
- Instrument, software and analysis versions
- Calibration, control and measurement-performance evidence
- Raw and processed return formats
- Known limitations, interference and uncertainty
Agree the analysis and evidence return before results exist
Record the scientist-defined transformations, normalisation, statistical method, missing-data treatment, uncertainty reporting and decision criteria before the result is known. A criterion declared after looking at the result should remain visible as exploratory rather than being rewritten into the original plan.
Specify what must return with the result: run and group identifiers, endpoint, timepoint, unit, replicate identity, raw rows, analysis version, deviations, unresolved discrepancies and correction history. The objective is not to force every laboratory into one system. It is to make the agreed evidence package explicit enough to review.
- Predeclared analysis plan or explicit exploratory status
- Normalisation and missing-data treatment
- Uncertainty and limitation reporting
- Required result schema and provenance
- Deviation and correction process
- Named owner for final interpretation
Treat laboratory capability as a declaration, not a verdict
The receiving laboratory should be able to declare which requirements it supports, what evidence supports that declaration, which substitutions it proposes and what remains unresolved. The sponsor can then decide whether to amend, clarify or stop the handoff.
A matching declaration is not proof of laboratory quality, method equivalence or outcome. It is a structured way to expose a gap before execution rather than discovering it when the report returns.
- Capability supported, unsupported or not evidenced
- Evidence source and current review state
- Proposed substitutions or deviations
- Named laboratory and sponsor owners
- Resolution recorded against an exact Study Contract version
Freeze the version and keep corrections visible
Before execution, bind the agreed Study Contract to the intended recipient and record acknowledgement. If a consequential detail changes, issue a successor version rather than editing the historical handoff. Returned observations, analysis and review should point to the exact version that governed the work.
This does not make the biology valid by itself. It gives the accountable scientist a traceable record of what was intended, what was declared, what changed and what evidence returned. That is the minimum foundation for a defensible review.
- Exact contract version and recipient
- Acknowledgement and unresolved findings
- Successor version for consequential amendments
- Returned observations linked to the governing version
- Correction history and accountable review state
Primary sources
Material claims were checked against the organisations responsible for the guidance or measurement work.
- NIH — Guidance: Rigor and Reproducibility in Grant Applications ↗National Institutes of Health · Research question, rigorous design, biological variables, resource authentication and transparent reporting.
- NIH — NOT-OD-17-068: Authentication of Key Biological and/or Chemical Resources ↗National Institutes of Health · Explicit identity and authentication plans for key biological resources, including cell lines.
- NIST — Cell Line Identification and Authentication ↗National Institute of Standards and Technology · Exact cell identity, provenance and context-specific authentication evidence.
- NIST — Building Measurement Confidence for Cell Characterization ↗National Institute of Standards and Technology · Fit-for-purpose measurement context, variability, uncertainty and performance evidence.
- NIST — Measurement Assurance Strategies ↗National Institute of Standards and Technology · Handling, matrix, reagent and process context that can affect biological measurements.
- NCBI Bookshelf / NCATS — Assay Guidance Manual, Preface ↗National Center for Advancing Translational Sciences · Assay purpose, biological relevance and fit-for-purpose performance.
Limitations
- This article describes documentation and handoff fields, not a biological protocol.
- It does not select an assay, control set, replicate count, statistical test or acceptance threshold.
- It does not establish laboratory or method equivalence, clinical suitability, manufacturing release or regulatory acceptance.
- A qualified project scientist must supply or approve study-specific values and interpretation.
See the handoff as a working system.
Explore one synthetic study from research question through capability comparison, returned results and review-required evidence.